TY  - JOUR
N2  - This review provides a detailed overview of how digital health can be utilized in the management of Interstitial Lung Disease (ILD), and Chronic Obstructive Pulmonary Disease (COPD). ILD encompasses a diverse range of lung disorders characterized by inflammation and scarring of lung tissue, leading to restrictive lung physiology and impaired gas exchange, with symptoms including progressive dyspnoea, cough, and hypoxia. COPD which ranks as the third leading cause of death globally, is characterized by chronic lung inflammation causing irreversible airflow obstruction, recurrent exacerbations. While recent advances in digital health have shown promise, predicting disease progression in patients with ILD and exacerbation in patients with COPD remains challenging. This review explores the role of digital health in managing ILD and COPD, particularly focusing on telehealth and digital health technologies. Telehealth, defined broadly as the use of electronic information and telecommunications technologies in healthcare, has become increasingly relevant, especially during the COVID-19 pandemic. This review examines the role of digital health technologies in the management of ILD and COPD, with particular focus on telemedicine, and digital health tools. Remote monitoring technologies, including home spirometry and wearable devices, have demonstrated feasibility in managing respiratory diseases. However, challenges such as evidence, data reliability, varying adherence, education, and the high costs of data collection and lack of qualified clinicians present barriers for many national health systems.
ID  - discovery10205574
PB  - Frontiers Media SA
UR  - https://doi.org/10.3389/fmed.2025.1361667
SN  - 2296-858X
JF  - Frontiers in Medicine
A1  - Althobiani, Malik A
A1  - Russell, Anne-Marie
A1  - Jacob, Joseph
A1  - Ranjan, Yatharth
A1  - Ahmad, Rami
A1  - Folarin, Amos A
A1  - Hurst, John R
A1  - Porter, Joanna C
KW  - Telehealth
KW  -  digital health
KW  -  mobile health (mHealth)
KW  -  interstitial lung diease
KW  -  chronic obstructive pulmonary disease
KW  -  respiratory disease
KW  -  artificial intelligence
KW  -  spirometry
TI  - The role of digital health in respiratory diseases management: a narrative review of recent literature
AV  - public
Y1  - 2025/02/26/
VL  - 12
N1  - © 2025 Althobiani, Russell, Jacob, Ranjan, Ahmad, Folarin, Hurst and Porter. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
ER  -